SR

Srinathan Rajagopalan

Active Director Cfo DIN 11320212
DIN 11320212 First appointment Sep 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Total affiliations 6 Since Sep 2025
Shareholding value •••• Premium profile

About Srinathan Rajagopalan

Data last updated:

Srinathan Rajagopalan is a Cfo at Medall Healthcare Private Limited (since 2025), Additional Director at Clumax Diagnostic And Research Centre Private Limited (since 2025) and Additional Director at Medall Scans And Labs Ranchi Private Limited (since 2025), and holds 3 more current directorships. The companies operate in Healthcare. The 5 current companies with reported revenue have a combined latest revenue of ₹196 Cr; the largest is Medall Healthcare Private Limited at ₹159 Cr (FY 2023).

DIN 11320212
Primary Designation Cfo
Industry Healthcare
First Appointment 11 Sep 2025
Oldest Company Age 32 yrs
Largest company Medall Healthcare Private Limited · ₹159 Cr (FY 2023)
Combined revenue ₹196 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medall Healthcare Private Limited U85110TN1994PTC029023
Cfo11 Sep 20251994₹159 Cr (FY 2023)Active
Additional Director27 Sep 20252004₹18.78 Cr (FY 2024)Active
Additional Director27 Sep 20252015₹18.08 Cr (FY 2024)Active
Additional Director27 Sep 20252011₹18.3 Lakh (FY 2024)Active
Additional Director27 Sep 20252013₹3.3 Lakh (FY 2024)Active
Medall Visakhapatnam Private Limited U85320TN2018PTC125701
Additional Director27 Sep 20252018Active

Directorship timeline

Open interactive timeline →
Medall Healthcare Private Limited
Medall Scans And Labs Ranchi Private Limited
Medall Scans And Labs Marthahalli Private Limited
Medall Visakhapatnam Private Limited
Premium access

Shareholding and investment profile for Srinathan Rajagopalan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinathan Rajagopalan

Srinathan Rajagopalan currently holds 6 directorships: Medall Healthcare Private Limited (Cfo, since 11 Sep 2025, revenue ₹159 Cr (FY 2023)); Clumax Diagnostic And Research Centre Private Limited (Additional Director, since 27 Sep 2025, revenue ₹18.78 Cr (FY 2024)); Medall Scans And Labs Ranchi Private Limited (Additional Director, since 27 Sep 2025, revenue ₹18.08 Cr (FY 2024)); Medall Scans And Labs Marthahalli Private Limited (Additional Director, since 27 Sep 2025, revenue ₹18.3 Lakh (FY 2024)); Medall Spark Diagnostics Nashik Private Limited (Additional Director, since 27 Sep 2025, revenue ₹3.3 Lakh (FY 2024)); and 1 more.

Srinathan Rajagopalan was first appointed on 11 Sep 2025 as Cfo at Medall Healthcare Private Limited.

The 5 current companies of Srinathan Rajagopalan that report revenue have a combined latest revenue of ₹196 Cr: Medall Healthcare Private Limited ₹159 Cr (FY 2023); Clumax Diagnostic And Research Centre Private Limited ₹18.78 Cr (FY 2024); Medall Scans And Labs Ranchi Private Limited ₹18.08 Cr (FY 2024); Medall Scans And Labs Marthahalli Private Limited ₹18.3 Lakh (FY 2024); Medall Spark Diagnostics Nashik Private Limited ₹3.3 Lakh (FY 2024).

The current boards of Srinathan Rajagopalan's companies include Aanchal Ramdev (Medall Healthcare Private Limited), Balakrishnan Janardhanan (Medall Healthcare Private Limited), Charles Edouard Paul Guy Rigoux (Medall Healthcare Private Limited), Mei Mei Michelle Lee (Medall Healthcare Private Limited), Rahul Goswamy (Medall Healthcare Private Limited), Sandeep Nadigadda Reddy (Medall Healthcare Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available